Synthetic biology – fact or fiction

Innovative technology producers are scaling at a rapid pace, deploying technology to partners and reinvesting in new biotech platforms. Can the technology keep pace? What are commercial examples? Is the syn bio unicorn able to produce sustainably at scale? What are the gaps in the supply chain? Where are the investments coming from and do we see these trends continue? Will the public accept these new technologies and what are the regulatory frameworks supporting their growth?